What is Deep 6 AI?
Founded in 2015 and headquartered in Pasadena, California, Deep 6 AI is a technology company focused on accelerating clinical trial patient recruitment. The platform aims to reduce the time it takes to find suitable candidates for life-saving cures from months to mere minutes, thereby expediting the delivery of new medical treatments to patients. The company's innovative approach addresses a critical bottleneck in the pharmaceutical and healthcare research sectors.
How much funding has Deep 6 AI raised?
Deep 6 AI has raised a total of $18.3M across 3 funding rounds:
Series A
$17M
Debt
$350K
Debt
$951K
Series A (2019): $17M with participation from Point72 and GSR Ventures
Debt (2020): $350K led by PPP
Debt (2021): $951K supported by PPP
Key Investors in Deep 6 AI
Point72
Point72 is a private investment management firm established in 1992, managing various private investment funds across different asset classes.
GSR Ventures
GSR Ventures is a venture capital firm that typically invests in early-stage technology companies, focusing on sectors like artificial intelligence and advanced manufacturing.
PPP
Public-Private Partnership
What's next for Deep 6 AI?
The recent major strategic investment signals a pivotal moment for Deep 6 AI, likely enabling the company to scale its operations, enhance its technology platform, and expand its market reach. This capital infusion is expected to fuel further innovation in patient identification for clinical trials, reinforcing its position as a key player in health tech and drug development acceleration. The company is poised for significant growth as it continues to streamline the research process.
See full Deep 6 AI company page
